SLC2A3 and metabolic dysfunction-associated steatotic liver disease: Future research endeavors will focus on quantifying WTAP lactylation levels and evaluating the activity of the WTAP-m6A-YTHDF1-GLUT3 axis in liver biopsy samples from patients diagnosed with MASLD, both in the presence and absence of H. pylori infection.